Navigation Links
Simeprevir Data in Hepatitis C Patients to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Date:10/1/2013

fectious disease of the liver and a leading cause of chronic liver disease, is the focus of a rapidly evolving treatment landscape. Approximately 150 million people are infected with hepatitis C worldwide – including approximately 3.2 million people in the United States – and 350,000 people per year die from the disease globally. When left untreated, hepatitis C can cause significant damage to the liver including cirrhosis. Additionally, hepatitis C may increase the risk of developing complications from cirrhosis, which may include liver failure.

About Janssen R&D Ireland
At Janssen, we are dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and healthcare solutions to help people throughout the world. Janssen R&D Ireland is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssenrnd.com for more information.

Media Contact: Daniel De Schryver
Mobile: +49 173 76 89 149

Media Contact: Craig Stoltz
Mobile: +1 (215) 325-3612

Investor Contact: Stan Panasewicz
Office: +1 (732) 524-2524

Investor Contact: Louise Mehrotra
Office: +1 (732) 524-6491


'/>"/>
SOURCE Janssen R&D Ireland
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
2. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
3. Janssen Submits New Drug Application to U.S. FDA for Simeprevir (TMC435) for Combination Treatment of Adult Patients with Genotype 1 Chronic Hepatitis C
4. Findings from Two Phase 3 Studies of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Genotype 1 Chronic Hepatitis C Patients
5. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
6. U.S. FDA Grants Priority Review to Simeprevir (TMC435) for Combination Treatment of Genotype 1 Chronic Hepatitis C
7. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
8. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
9. Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
10. Bulgaria Launches Development of National Hepatitis Plan
11. Major Breakthrough in Hepatitis C Vaccine Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces ... Ltd., has received Chinese FDA (CFDA) approval and ... Tablets into the China ... and distribution agreement with Sinochem Jiangsu Pharmaceutical Co., ... US FDA approved and China CFDA certified oral ...
(Date:8/20/2014)... LOS ANGELES , Aug. 20, 2014   Easy Breathe ... today announced that its " Easy Blog " - has received ... the year.   "We are thrilled that so many ... Nick Weiss , CEO of Easy Breathe. "We,re committed to making ... use Easy Blog to stay informed about sleep apnea news ...
(Date:8/20/2014)... MUMBAI , August 20, 2014 ... owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), ... studies of a novel clinical development candidate, GBR ... discovered and developed by the Glenmark Biologics Research ... . GBR 1302 is based on Glenmark,s ...
Breaking Medicine Technology:Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3
... Response Rate and 100% Disease Control Rate Observed in ... Patients with Medullary Thyroid Cancer, CHICAGO, June ... from an ongoing phase 1 clinical trial of,XL184, a novel small ... The maximum tolerated dose (MTD) for,XL184 has been determined to be ...
... Recipients with Cancer, HERSHEY, Pa., June 1 ... cancer is challenging.,Clinicians must balance the need to ... of chemotherapeutic agents on a,patient,s immune system., ... will be,presented today at the American Transplant Congress ...
Cached Medicine Technology:Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 2Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 3Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 4Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 5Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 6Penn State Hershey Transplant Program Uses Assay to Monitor Cell-Mediated Immunity 2
(Date:8/21/2014)... AttorneyOne.com, a recognized authority on law, update ... the FDA on Dianeal Low Calcium (2.5mEq/L) Peritoneal ... August 15, that two lots of Dianeal Low Calcium ... II), by Baxter International Inc., are recalled ... The reason for the recall is the presence of ...
(Date:8/21/2014)... MISSOULA, Mont. (PRWEB) August 21, 2014 She ... struck blind and brain injured after a surgery to correct ... “He Works All Things Together…” author Rebecca Strom-Stewart shares her ... misguided good intentions that led to a miscarriage of justice ... trudge through the tunnel of darkness and into the light,” ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 Michael E. ... his Judaic roots back to the Bluff City with recent ... Jews, even those in the United States,” says friend and ... through various outreach programs, such as providing in-house for the ... with Israel by serving in the local synagogue. And to ...
(Date:8/21/2014)... Recently nominated as the Women’s Radio Network’s ... to be the man he is today. Growing up, KC ... positive look on women, respecting them as professionals and individuals. Through ... thanks to a man who he had the pleasure of working ... KC Armstrong’s name will ring a bell to most of you ...
(Date:8/20/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) ... announced Bluehost ( http://www.bluehost.com/track/seohosts ), MaxCDN, and Justhost ... high quality PHP hosting at affordable rates. , ... Hosting are unbiased and entirely independent, ensuring that ... During the recent years, web hosting industry has ...
Breaking Medicine News(10 mins):Health News:Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II) Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:The Dramatic, Uplifting Story from a Brain Injured Woman 2Health News:WRNW1's KC Armstrong Expresses Thanks and Appreciation to Howard Stern 2Health News:New Reviews Of Cheap PHP Hosting Companies Unveiled By Top 10 Best SEO Hosting 2
... is better for health than clear juice where the pulp is ... absorb chemicals known to damage cells in the body //- and ... well as heart disease. ,Most consumers prefer clear ... levels of polyphenols were found to be more in juices with ...
... eggs that can be used to produce drugs like those used ... Edinburgh, Scotland have claimed to create a flock of ... create life saving drugs. ,These drugs could in ... Health Service incurs, according to them. , For disbelievers, ...
... delivered in lipid-based nanoparticles drastically reduces the number ... tumors in mice, researchers at The University of ... University of Texas Southwestern Medical Center report in ... ,Two tumor-suppressing genes given intravenously reduced cancer separately ...
... one of the most devastating conditions of older age. ... and 24 million worldwide, dementia leads //to total loss ... making it one of people’s greatest fears of aging. ... and serious complication in older individuals that often follows ...
... armored vests and other protective gear, streamlined systems ... approaches—have combined to produce significant improvement// in the ... and Afghanistan, according to a Special Editorial in ... Surgery. ,For soldiers injured in combat today, ...
... doctors in England views their future job prospects as ... in training and healthcare delivery, //reveals a survey* published ... Medical Journal. ,While the government plans to ... conditions, away from hospitals into the community, almost a ...
Cached Medicine News:Health News:No Pills Just Omelets 2Health News:Dual Gene Therapy Suppresses Lung Cancer in Preclinical Test 2Health News:Relationship Between Delirium and Dementia 2Health News:Relationship Between Delirium and Dementia 3Health News:Relationship Between Delirium and Dementia 4Health News:Advances Have Cut Combat Deaths in Iraq and Afghanistan 2Health News:One in Four Specialist Trainee Doctors 'Very Worried' About Future Job Prospects 2
This instrument measures intraocular pressure without,contacting. Alignment is performed semi-automatically....
... InfusO.R. Pump is a syringe ... in the administration of many ... procedures. It provides for the ... relaxants, and vasoactive drugs through ...
... Management System answers the day-to-day needs ... flexibility. From programming to data retrieval, ... management right where you want it. ... to help each patient become ambulatory ...
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology....
Medicine Products: